[1]冯瑞丰.早期慢性阻塞性肺疾病诊断与防治研究[J].医学信息,2019,32(21):40-42.[doi:10.3969/j.issn.1006-1959.2019.21.014]
　FENG Rui-feng.Diagnosis and Prevention of Early Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(21):40-42.[doi:10.3969/j.issn.1006-1959.2019.21.014]
点击复制

早期慢性阻塞性肺疾病诊断与防治研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年21期
页码:
40-42
栏目:
综述
出版日期:
2019-11-01

文章信息/Info

Title:
Diagnosis and Prevention of Early Chronic Obstructive Pulmonary Disease
文章编号:
1006-1959（2019）21-0040-03
作者:
冯瑞丰
（天津市宝坻区人民医院/天津医科大学宝坻临床学院呼吸科，天津 301800）
Author(s):
FENG Rui-feng
(Department of Respiratory,Tianjin Baodi District People's Hospital/Baodi Clinical College, Tianjin Medical University,Tianjin 301800,China)
关键词:
慢性阻塞性肺疾病; 早期; 肺功能
Keywords:
Chronic obstructive pulmonary disease; Early; Lung function
分类号:
R563
DOI:
10.3969/j.issn.1006-1959.2019.21.014
文献标志码:
A
摘要:
慢性阻塞性肺疾病（COPD）是以持续气流受阻进行性发展为特征的一种可预防和治疗的疾病。COPD发病率、致残率较高，严重威胁人类健康安全。目前，早发现、早诊断、早治疗是我国COPD防治的重要手段。我国早期COPD病例数量大，不同患者症状存在明显差异性。研究早期COPD诊治情况，有望探索对患者进行个体化治疗的方法，进一步促进临床治疗策略的制定，提高慢性阻塞性肺疾的临床诊治研究水平。本文现就COPD早期的诊治研究进行综述，以期为临床诊治慢性阻塞性肺疾提供理论参考依据。
Abstract:
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterized by progressive progression of obstructed airflow. The incidence and disability rate of COPD is high, which is a serious threat to human health and safety. At present, early detection, early diagnosis and early treatment are important means of prevention and treatment of COPD in China. The number of early COPD cases in China is large, and the symptoms of different patients are significantly different. Studying the diagnosis and treatment of early COPD, it is expected to explore ways to individualized treatment of patients, further promote the formulation of clinical treatment strategies, and improve the clinical diagnosis and treatment of chronic obstructive pulmonary disease. This article reviews the early diagnosis and treatment of COPD in order to provide a theoretical reference for clinical diagnosis and treatment of chronic obstructive pulmonary disease.

参考文献/References:

[1]中华医学会呼吸病学分会慢性阻塞性肺疾病学组．慢性阻塞性肺疾病诊治指南(2013年修订版)［J］．中国医学前沿杂志(电子版),2014,6(2):67-80． [2]Lutchmedial SM,Creed WG,Moore AJ,et al.How Common Is Airflow Limitation in Patients With Emphysema on CT Scan of the Chest[J].Chest,2015,148(1):176-184. [3]石喆,王石林,汪海燕,等.适宜国人BMI 分级的慢性阻塞性肺疾病筛查问卷的检验与评价[J].中华全科医师杂志,2014,13(3):184-187. [4]金哲,王广发.慢性阻塞性肺疾病全球倡议(2014 更新版)解读[J].中国医学前沿杂志(电子版),2014,6(2):94-97. [5]纪春东,于秀芹,赖永新,等.某区慢性阻塞性肺疾病患者认知和诊疗现状的分析[J].中国医药指南,2016,14(2):142-143. [6]亓梅,韩其政,贾曰林,等.山东省慢性阻塞性肺疾病患者疾病认知水平及治疗现状[J].解放军预防医学杂志,2015,33(6):656-657. [7]Jones RC,Price D,Ryan D,et al.Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort[J].Lancet Respir Med,2014,2(4):267-276. [8]包鹤龄,方利文,王临虹.1990-2014年中国40岁及以上人群慢性阻塞性肺疾病患病率Meta分析[J].中华流行病学杂志,2016,37(1):119-124. [9]刘亚男,许文兵,孟淑珍,等.探究峰流速仪呼气峰流速检测对慢性阻塞性肺疾病的筛查效力[J].中国呼吸与危重监护杂志,2015,14(3):250-254. [10]Casaburi R,Duvall K.Improving Early-Stage Diagnosis and Managementof COPD in Primary Care[J].Postgrad Med,2014, 126(4):141-154. [11]王永新.慢性阻塞性肺病患者稳定期肺弥散功能检测意义[J].中国医药科学,2014,4(15):126-128. [12]罗军,纪祥,张柏林.CT肺容积扫描诊断慢性阻塞性肺疾病的临床意义[J].实用医院临床杂志,2016,13(1):41-43. [13]Chen X,Wang N,Chen Y,et al.Costs of chronic obstructive pulmonarydisease in urban areas of China: a cross-sectional studyin four cities[J].Int J Chron Obstruct Pulmon Dis,2016(11): 2625-2632. [14]Patel HJ.An update on pharmacologic management of chronic obstructivepulmonary disease[J]. Curr Opin Pulm Med,2016,22(2):119-124. [15]Welte T,Vogelmeier C,Papi A.COPD early diagnosis and treatmentto slow disease progression[J].Int J Clin Pract,2015,69(3):336-349. [16]沈楚婕,张伟.慢性阻塞性肺疾病早期筛查方法及临床意义[J].国际呼吸杂志,2015,35(15):1144-1148. [17]柳涛,蔡柏蔷.慢性阻塞性肺疾病诊断、处理和预防全球策略(2011年修订版)介绍[J].中国呼吸与危重监护杂志,2014,11(1):1-12. [18]Pleasants RA,Ohar JA,Croft JB,et al.Chronic obstructivepulmonary disease and asthma-patient characteristicsand health impairment[J].COPD,2014,11(3):256-266. [19]赖富华.慢性阻塞性肺疾病早期干预的再认识[J].重庆医学,2015,42(12):1415-1417. [20]钟南山.早发现、早诊断和早干预应是我国慢性阻塞性肺疾病防治的主要研究方向[J].中华结核和呼吸杂志,2015,35(4):243-245. [21]张富强,郑劲平,王佳泓,等.慢性阻塞性肺疾病支气管舒张验后肺容量和呼气流量反应的差别[J].中华结核和呼吸杂志,2014,33(2):109-113. [22]Vogelmeier CF,Criner GJ,Martinez FJ,et al.Global Strategy for the Diagnosis,Management and Prevention of Chronic Obstructive Lung Disease 2017 Report.GOLD Executive Summary[J].Am J Respir Crit Care Med,2017,195(5):557-582.

相似文献/References:

[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
　ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(21):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
　CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(21):124.[doi:10.3969/j.issn.1006-1959.2018.02.045]
[3]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
　WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Journal of Medical Information,2018,31(21):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[4]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
　LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(21):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[5]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[6]罗 倩.COPD加重期患者肺功能、血气指标及 炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
　LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Journal of Medical Information,2018,31(21):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[7]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病 引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
　ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(21):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[8]金彦青.NPPV治疗慢性阻塞性肺疾病合并 重症呼吸衰竭的临床疗效观察[J].医学信息,2018,31(14):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
　JIN Yan-qing.Clinical Efficacy of NPPV in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure[J].Journal of Medical Information,2018,31(21):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
[9]何冬兰,李 文.NLR、PLR在慢性阻塞性肺疾病进展、预后中的相关研究[J].医学信息,2022,35(11):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
　HE Dong-lan,LI Wen.Study on Correlation Between NLR and PLR in the Progression and Prognosis of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(21):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
[10]张 林,白 俐.扶正化瘀胶囊对慢性阻塞性肺疾病患者炎性因子及 MMP-9、TIMP-1的影响[J].医学信息,2018,31(14):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
　ZHANG Lin,BAI Li.Effect of Fuzheng Huayu Capsule on Inflammatory Factors,MMP-9 and TIMP-1 in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(21):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]

更新日期/Last Update: 2019-11-01